Interleukin-17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis
- PMID: 32249470
- DOI: 10.1111/jdv.16416
Interleukin-17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis
Similar articles
-
Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15).Am J Ophthalmol. 2003 Nov;136(5):933-5. doi: 10.1016/s0002-9394(03)00892-4. Am J Ophthalmol. 2003. PMID: 14597055
-
A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?Mod Rheumatol. 2013 Jul;23(4):837-9. doi: 10.1007/s10165-012-0720-z. Epub 2012 Jul 21. Mod Rheumatol. 2013. PMID: 22821420
-
A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.Innate Immun. 2017 Oct;23(7):578-583. doi: 10.1177/1753425917727063. Epub 2017 Aug 24. Innate Immun. 2017. PMID: 28836875
-
Computational model to analyze and characterize the functional mutations of NOD2 protein causing inflammatory disorder - Blau syndrome.Adv Protein Chem Struct Biol. 2020;120:379-408. doi: 10.1016/bs.apcsb.2019.11.005. Epub 2020 Feb 4. Adv Protein Chem Struct Biol. 2020. PMID: 32085886 Review.
-
[The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].Nihon Rinsho. 2013 Apr;71(4):737-41. Nihon Rinsho. 2013. PMID: 23678609 Review. Japanese.
References
-
- McGeachyMJ, CuaDJ, GaffenSL. The IL-17 family of cytokines in health and disease. Immunity 2019; 50: 892-906.
-
- OrrellKA, MurphreyM, KelmRC et al. Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: postmarketing analysis from the RADAR ("Research on Adverse Drug events And Reports") program. J Am Acad Dermatol 2018; 79: 777-778.
-
- NyckowskiT, CeilleyR, WilsonJ. Sarcoidosis developing during secukinumab therapy: case report. J Cutan Med 2017; 1: 5.
-
- SambhariaM, MaggeT, RamakrishnaS. worsening of pulmonary sarcoidosis induced by ixekizumab: a rare paradox. Chest 2018; 154: 898A.
-
- WangA, HornickN, LimY et al. IL-17 blockade downregulates NOD2 in skin and may promote ‘paradoxical’ sarcoidosis. J Eur Acad Dermatol Venereol 2020; https://doi.org/10.1111/jdv.16416
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical